Nizhpharm
Prescription Drugs
1open role
Scaling fasthiring pace, 82 of 100
1-10people
10stories in the press
Overview
Nizhpharm is a Russian pharmaceutical manufacturer producing prescription medicines. Its postings cover 1C functional architects and analysts, business analysts for data warehouse, BI and reporting, strategic analytics and data management leadership, mostly in Moscow. The company is based in Russia.
Jobs
≈ $19k – $47k per year (Estimated) · Hybrid · Moscow
Python
SQL
Power BI
Apply
Growth
Hiring Momentum
82/100
Scaling fast
Open positions
8
7 opened / 7 closed in 30 days
Median time-to-fill
30 days
faster than 44% of the market
ATS activity
Every ~23 hours
11/07/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Analytics
31% ▼
Field & Service
21%
Marketing
17% ▼
Enterprise Apps
14%
Sales
7% ▲
Backend
3% ▼
Activity Timeline
Added Trello to stack
Oct 2026
Added Microsoft Office to stack
Oct 2026
Added Figma to stack
Oct 2026
Added PostgreSQL to stack
Oct 2026
Added Waterfall to stack
Sep 2026
Added ITIL to stack
Sep 2026
Added UML to stack
Sep 2026
Added ITSM to stack
Sep 2026
Added BPMN to stack
Sep 2026
Added 1C to stack
Sep 2026
Added Data Vault to stack
Sep 2026
Added Scrum to stack
Sep 2026
Tech stack
Technologies named in job postings at Nizhpharm over the last 12 months, by layer, with the share of postings for each.
Technologies in use
14
Postings analysed
22
Stack modernity
76/100
Languages
SQL64%
1C27%
Python18%
Databases
MS SQL32%
PostgreSQL9%
Cloud & platforms
Power BI45%
SSAS32%
Airflow18%
Figma5%
Sign in to see how your skills match this stack
Sign In
Full Nizhpharm tech stack
14 technologies · by team · pay by technology · changes · similar stacks
News
The FAS recognized Nizhpharm as violating the law "On Advertising"
The FAS recognized Nizhpharm as violating the law "On Advertising" The Company will be brought to administrative responsibility in accordance with the Administrative Code of the Russian Federation. AKM.RU
Read more
Report
微芯生物：西达本胺授权Nizhpharm首付款达1000万元_医疗_产经频道首页_财经网 - CAIJING.COM.CN
微芯生物：西达本胺授权Nizhpharm首付款达1000万元
Read more
Report
深圳微芯生物科技股份有限公司关于与Nizhpharm签署许可及分销协议的公告
证券代码：688321 证券简称：微芯生物 公告编号：2026-011深圳微芯生物科技股份有限公司关于与Nizhpharm签署许可及分销协议的公告本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏并对其内容的...
Read more
Report
微芯生物与Nizhpharm签署西达本胺许可及分销协议_腾讯新闻
智通财经APP讯微芯生物(688321.SH)发布公告公司与Nizhny Novgorod Chemical Pharmaceutical Plant(简称
Read more
Report
微芯生物：与Nizhpharm签署许可及分销协议_腾讯新闻
格隆汇2月3日丨微芯生物(688321.SH)公布公司与Nizhny Novgorod Chemical Pharmaceutical Plant以下简称
Read more
Report
微芯生物：与Nizhpharm就西达本胺签署许可及分销协议 _ 东方财富网
上证报中国证券网讯记者潘建樑微芯生物晚间公告公司与NizhnyNovgorodChemicalPharmaceuticalPlant以下简称
Read more
Report
微芯生物：与Nizhpharm签署西达本胺许可及分销协议 _ 东方财富网
微芯生物：与Nizhpharm签署西达本胺许可及分销协议微芯生物(688321)2月3日公告公司与NizhnyNovgorodChemicalPharmaceuticalPlant简称
Read more
Report
The owner of Nizhpharm has changed the title owner
The owner of Nizhpharm has changed the title owner The Russian company is now owned by Luxembourg-based NIDDA. AKM.RU
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Moscow
Moscow
Russia
Sales office
8 open roles 29 posted in 90 days 13% engineering 1-10 est. staff
hires for Marketing, Sales, Field & Service
Пресненская набережная 6с2